Metraipolis › archive › dc_f733bc807ed5
Impact of cardiometabolic health on treatment outcomes in early-stage triple-negative breast cancer receiving chemoimmunotherapy — Europe PMC PMID:42283783
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42283783
- DOI
- 10.1007/s10549-[numero omesso]-5
- License (as archived)
- solo-consultazione
- Archived
- 2026-10-31T13:16:51.203Z
- SHA-256 of the archived text
54b495988c5d06011b51722b60f12370f330f3f57fd3a79d54a674fc9bb84a19- Stable URL of this page
https://metraipolis.com/documento/dc_f733bc807ed5
How to cite
Impact of cardiometabolic health on treatment outcomes in early-stage triple-negative breast cancer receiving chemoimmunotherapy — Europe PMC PMID:42283783 — Europe PMC (en), https://europepmc.org/article/MED/42283783 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_f733bc807ed5 (Metraipolis archive dc_f733bc807ed5, sha256 54b495988c5d06011b51722b60f12370f330f3f57fd3a79d54a674fc9bb84a19)
BibTeX
@misc{dcf733bc807ed5,
title = {Impact of cardiometabolic health on treatment outcomes in early-stage triple-negative breast cancer receiving chemoimmunotherapy — Europe PMC PMID:42283783},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42283783},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_f733bc807ed5; sha256 54b495988c5d06011b51722b60f12370f330f3f57fd3a79d54a674fc9bb84a19},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42283783. Agents can read the archived copy with the MCP tool read_document.